Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: additional evidence for the concept of 'smokers' paradox'.

Park KW, Kang SH, Kang J, Jeon KH, Park JJ, Han JK, Koh JS, Lee SE, Yang HM, Lee HY, Kang HJ, Koo BK, Oh BH, Park YB, Kim HS.

Heart. 2012 Jul;98(13):1000-6. doi: 10.1136/heartjnl-2011-301565. Epub 2012 May 9.

PMID:
22572048
2.

Clinical outcomes of high on-treatment platelet reactivity in Koreans receiving elective percutaneous coronary intervention (from results of the CROSS VERIFY study).

Park KW, Jeon KH, Kang SH, Oh IY, Cho HJ, Lee HY, Kang HJ, Park SK, Koo BK, Oh BH, Park YB, Kim HS.

Am J Cardiol. 2011 Dec 1;108(11):1556-63. doi: 10.1016/j.amjcard.2011.07.012. Epub 2011 Aug 30.

PMID:
21880289
3.

Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial.

Reed GW, Cannon CP, Waalen J, Teirstein PS, Tanguay JF, Berger PB, Angiolillo DJ, Price MJ.

Catheter Cardiovasc Interv. 2017 Feb 1;89(2):190-198. doi: 10.1002/ccd.26428. Epub 2016 Feb 23.

PMID:
26909669
4.

Cigarette Smoking Does Not Enhance Clopidogrel Responsiveness After Adjusting VerifyNow P2Y12 Reaction Unit for the Influence of Hemoglobin Level.

Kim YG, Suh JW, Kang SH, Park JJ, Yoon CH, Cho YS, Youn TJ, Chae IH, Choi DJ, Kim HS.

JACC Cardiovasc Interv. 2016 Aug 22;9(16):1680-90. doi: 10.1016/j.jcin.2016.05.036.

5.

Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy.

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW.

Thromb Res. 2009 Nov;124(5):588-91. doi: 10.1016/j.thromres.2009.06.012. Epub 2009 Jul 23.

PMID:
19631365
6.

Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial.

Cornel JH, Ohman EM, Neely B, Clemmensen P, Sritara P, Zamoryakhin D, Armstrong PW, Prabhakaran D, White HD, Fox KA, Gurbel PA, Roe MT; TRILOGY ACS Investigators.

Am Heart J. 2014 Jul;168(1):76-87.e1. doi: 10.1016/j.ahj.2014.04.011. Epub 2014 Apr 24. Erratum in: Am Heart J. 2014 Oct;168(4):605.

PMID:
24952863
7.

Smoking, atherothrombosis and clopidogrel.

Warner TD, Paul-Clark M, Mitchell JA.

Heart. 2012 Jul;98(13):963-4. doi: 10.1136/heartjnl-2012-301903. No abstract available.

PMID:
22668863
8.

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.

Malinin A, Pokov A, Spergling M, Defranco A, Schwartz K, Schwartz D, Mahmud E, Atar D, Serebruany V.

Thromb Res. 2007;119(3):277-84. Epub 2006 Mar 24.

PMID:
16563469
9.

Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.

Ueno M, Ferreiro JL, Desai B, Tomasello SD, Tello-Montoliu A, Capodanno D, Capranzano P, Kodali M, Dharmashankar K, Charlton RK, Bass TA, Angiolillo DJ.

JACC Cardiovasc Interv. 2012 Mar;5(3):293-300. doi: 10.1016/j.jcin.2011.09.027.

10.

Enhanced clopidogrel responsiveness in smokers: smokers' paradox is dependent on cytochrome P450 CYP1A2 status.

Park KW, Park JJ, Jeon KH, Kang SH, Oh IY, Yang HM, Cho HJ, Lee HY, Kang HJ, Koo BK, Oh BH, Park YB, Kim HS.

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):665-71. doi: 10.1161/ATVBAHA.110.217182. Epub 2010 Dec 9.

11.

CYP3A4 genetic status may be associated with increased vulnerability to the inhibitory effect of calcium-channel blockers on clopidogrel.

Park JJ, Park KW, Kang J, Jeon KH, Kang SH, Ahn HS, Han JK, Koh JS, Lee SE, Yang HM, Lee HY, Kang HJ, Koo BK, Oh BH, Park YB, Kim HS.

Circ J. 2013;77(5):1289-96. Epub 2013 Feb 9.

12.
13.

Relationship between smoking and responsiveness to clopidogrel in non-cardiogenic ischemic stroke patients.

Maruyama H, Fukuoka T, Deguchi I, Ohe Y, Horiuchi Y, Kato Y, Sehara Y, Nagamine Y, Sano H, Hayashi T, Tanahashi N.

Intern Med. 2014;53(22):2575-9. Epub 2014 Nov 15.

14.

Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy.

Hochholzer W, Trenk D, Mega JL, Morath T, Stratz C, Valina CM, O'Donoghue ML, Bernlochner I, Contant CF, Guo J, Sabatine MS, Schömig A, Neumann FJ, Kastrati A, Wiviott SD, Sibbing D.

Am Heart J. 2011 Sep;162(3):518-26.e5. doi: 10.1016/j.ahj.2011.06.005. Epub 2011 Aug 11.

PMID:
21884870
15.

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.

Price MJ, Berger PB, Angiolillo DJ, Teirstein PS, Tanguay JF, Kandzari DE, Cannon CP, Topol EJ.

Am Heart J. 2009 May;157(5):818-24, 824.e1. doi: 10.1016/j.ahj.2009.02.012.

PMID:
19376306
16.

Smoking at least 10 cigarettes per day increases platelet inhibition by clopidogrel in patients with ST-segment-elevation myocardial infarction.

Jeong YH, Cho JH, Kang MK, Koh JS, Kim IS, Park Y, Hwang SJ, Kwak CH, Hwang JY.

Thromb Res. 2010 Oct;126(4):e334-8. doi: 10.1016/j.thromres.2010.03.020. Epub 2010 May 6.

PMID:
20451242
17.
18.

Correlation Between SNPs in Candidate Genes and VerifyNow-Detected Platelet Responsiveness to Aspirin and Clopidogrel Treatment.

Cui H, Lin S, Chen X, Gao W, Li X, Zhou H, Du W, Wang S, Zhao R.

Cardiovasc Drugs Ther. 2015 Apr;29(2):137-46. doi: 10.1007/s10557-015-6585-6.

PMID:
25860557
19.

Does the response to aspirin and clopidogrel vary over 6 months in patients with ischemic heart disease?

Khanna V, Mikael R, Thayalasamy K, Sambu N, Dimitrov BD, Englyst N, Calver AL, Corbett S, Gray H, Simpson IA, Wilkinson JR, Curzen N.

J Thromb Haemost. 2015 Jun;13(6):920-30. doi: 10.1111/jth.12909. Epub 2015 Apr 23.

20.

P2Y12 platelet reactivity after thrombolytic therapy for ST-segment elevation myocardial infarction.

Diego A, de Prado AP, Cuellas C, de Miguel A, Samaniego B, Alonso-Rodríguez D, Bangueses R, Vega B, Martín J, Fernandez-Vazquez F.

Thromb Res. 2012 Sep;130(3):e31-6. doi: 10.1016/j.thromres.2012.05.031. Epub 2012 Jun 14.

PMID:
22704077

Supplemental Content

Support Center